Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy

被引:2
|
作者
Mione, Cecile [1 ]
Casile, Melanie [2 ,3 ,4 ]
Moreau, Juliette [1 ]
Miroir, Jessica [1 ]
Molnar, Ioana [2 ,3 ,4 ]
Chautard, Emmanuel [1 ,2 ]
Bernadach, Maureen [3 ,4 ,5 ]
Kossai, Myriam [2 ,6 ]
Saroul, Nicolas [7 ]
Martin, F. [1 ]
Pham-Dang, Nathalie [8 ]
Lapeyre, Michel [1 ]
Biau, Julian [1 ,2 ]
机构
[1] Ctr Jean Perrin, Dept Radiat Therapy, Clermont Ferrand, France
[2] Univ Clermont Auvergne, INSERM U1240, IMoST, Clermont Ferrand, France
[3] Clin Invest Ctr, UMR 501, Clermont Ferrand, France
[4] Ctr Jean Perrin, Dept Clin Res Clin Search & Innovat, Clermont Ferrand, France
[5] Jean Perrin Ctr, Med Oncol Dept, Clermont Ferrand, France
[6] Ctr Jean Perrin, Dept Pathol & Mol Pathol, Clermont Ferrand, France
[7] Clermont Ferrand Univ Hosp, Dept Otolaryngol Head & Neck Surg, Clermont Ferrand, France
[8] Clermont Ferrand Univ Hosp, Dept Maxillofacial Surg, Clermont Ferrand, France
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
head and neck cancer; radiotherapy; post-operative; VMAT; recurrences; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; NECK-CANCER; RADIATION-THERAPY; TARGET DELINEATION; NCIC CTG; RADIOTHERAPY; PATTERNS; FAILURE; CHEMOTHERAPY;
D O I
10.3389/fonc.2023.1272856
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focus on loco-regional patterns of failure.Material and methods: Between 2011 and 2019, 167 patients were included (40% of oropharyngeal cancers, and 60% of oral cavity cancers). The median age was 60 years. There was 64.2% of stage IV cancers. All patients had both T and N surgery. 34% had a R1 margin, 42% had perineural invasion. 72% had a positive neck dissection and 42% extranodal extension (ENE). All patients were treated with VMAT with simultaneous integrated boost with three dose levels: 66Gy in case of R1 margin and/or ENE, 59.4-60Gy on the tumor bed, and 54Gy on the prophylactic areas. Concomittant cisplatin was administrated concomitantly when feasible in case of R1 and/or ENE.Results: The 1- and 2-year loco-regional control rates were 88.6% and 85.6% respectively. Higher tumor stage (T3/T4), the presence of PNI, and time from surgery >45 days were significant predictive factors of worse loco-regional control in multivariate analysis (p=0.02, p=0.04, and p=0.02). There were 17 local recurrences: 11 (64%) were considered as infield, 4 (24%) as marginal, and 2 (12%) as outfield. There were 9 regional recurrences only, 8 (89%) were considered as infield, and 1 (11%) as outfield. The 1- and 2-year disease-free survival (DFS) rates were 78.9% and 71.8% respectively. The 1- and 2-year overall survival (OS) rates were 88.6% and 80% respectively. Higher tumor stage (T3/T4) and the presence of ENE were the two prognostic factors significantly associated with worse DFS and OS in multivariate analysis.Conclusion: Our outcomes for postoperative VMAT for oral cavity and oropharyngeal cancers are encouraging, with high rates of loco-regional control. However, the management of ENE still seems challenging.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy
    Quinlan-Davidson, Sean R.
    Mohamed, Abdallah S. R.
    Myers, Jeffrey N.
    Gunn, Gary B.
    Johnson, Faye M.
    Skinner, Heath
    Beadle, Beth M.
    Gillenwater, Ann M.
    Phan, Jack
    Frank, Steven J.
    William, William N.
    Wong, Andrew J.
    Lai, Stephen Y.
    Fuller, Clifton D.
    Morrison, William H.
    Rosenthal, David I.
    Garden, Adam S.
    ORAL ONCOLOGY, 2017, 72 : 90 - 97
  • [2] Intensity-modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity
    Chen, Pang-Yu
    Chen, Helen H. W.
    Hsiao, Jenn-Ren
    Yang, Ming-Wei
    Hsueh, Wei-Ting
    Tasi, Sen-Tien
    Lin, Forn-Chia
    Wu, Yuan-Hua
    ORAL ONCOLOGY, 2012, 48 (08) : 747 - 752
  • [3] Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis
    Mazzola, Rosario
    Ricchetti, Francesco
    Fersino, Sergio
    Fiorentino, Alba
    Levra, Niccolo Giaj
    Di Paola, Gioacchino
    Ruggieri, Ruggero
    Alongi, Filippo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E815 - E819
  • [4] Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT
    Studer, Gabriela
    Glanzmann, Christoph
    ORAL ONCOLOGY, 2013, 49 (03) : 269 - 276
  • [5] Prognostic nutritional index relevance in chemoradiotherapy for advanced oral cavity, oropharyngeal and hypopharyngeal cancer
    Chang, Pei-Hung
    Hsieh, Jason Chia-Hsun
    Yeh, Kun-Yun
    Chen, Eric Yen-Chao
    Yang, Shih-Wei
    Huang, Jen-Seng
    Lai, Chien-Hong
    Wu, Tsung-Han
    Huang, Yen-Min
    Chang, Yueh-Shih
    Chou, Wen-Chi
    Wang, Cheng-Hsu
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2018, 27 (05) : 996 - 1001
  • [6] Osteoradionecrosis of the Mandible in Patients With Oropharyngeal Carcinoma Treated With Intensity-Modulated Rradiotherapy
    Caparrotti, Francesca
    Huang, Shao Hui
    Lu, Lin
    Bratman, Scott V.
    Ringash, Jolie
    Bayley, Andrew
    Cho, John
    Giuliani, Meredith
    Kim, John
    Waldron, John
    Hansen, Aaron
    Tong, Li
    Xu, Wei
    O'Sullivan, Brian
    Wood, Robert
    Goldstein, David
    Hope, Andrew
    CANCER, 2017, 123 (19) : 3691 - 3700
  • [7] Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
    Roskies, M.
    Kay-Rivest, E.
    Mascarella, M. A.
    Sultanem, K.
    Mlynarek, A.
    Hier, M.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 45 : 1 - 6
  • [8] Hippocampus sparing volumetric modulated arc therapy in patients with loco-regionally advanced oropharyngeal cancer
    Seol, Seung Won
    Lee, Brian H.
    Sita, Timothy L.
    Devineni, Jay Ram
    Kruser, Tim J.
    Sachdev, Sean
    Gentile, Michelle
    Helenowski, Irene
    Mittal, Bharat B.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 24 : 71 - 75
  • [9] Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer
    Liu, Shih-Hua
    Chao, K. S. Clifford
    Leu, Yi-Shing
    Lee, Jehn-Chuan
    Liu, Chung-Ji
    Huang, Yu-Chuen
    Chang, Yi-Fang
    Chen, Hong-Wen
    Tsai, Jo-Ting
    Chen, Yu-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (07): : 933 - 939
  • [10] Outcomes After Oral Cavity and Oropharyngeal Salvage Surgery
    Sharma, Bhavya K.
    Contrera, Kevin J.
    Jia, Xuefei
    Fleming, Christopher
    Lorenz, Robert R.
    Koyfman, Shlomo A.
    Mahomva, Chengetai
    Arianpour, Khashayar
    Burkey, Brian B.
    Fritz, Michael
    Ku, Jamie A.
    Lamarre, Eric D.
    Scharpf, Joseph
    Prendes, Brandon L.
    LARYNGOSCOPE, 2022, 132 (10) : 1984 - 1992